Google health-company CEO cuts ties with Roche

Following Wednesday’s announcement that Google spin-off Calico and drug firm AbbVie will spend up to $1.5 billion on age-related treatments, Calico CEO Art Levinson is stepping down from another drug firm’s board to avoid a conflict of interest.

Levinson said he’ll resign as a director of Swiss giant Roche, which owns South San Francisco biotech company Genentech, where Levinson was CEO from 1995 to 2009.

In a press release, Roche Chairman Christoph Franz said, “we regret Art’s decision but at the same time understand his reasons.”

Photo by Patrick Tehan, Mercury News

 

Tags: , , ,

 

Share this Post



 
 
 
 
 
css.php